Glaucoma Flashcards
1
Q
Features of Glaucoma
A
- changes in optic nerve head
- loss of visual sensitivity and field
- increased IOP
- incidence increases with age, black > white
2
Q
Pathophysiology of Glaucoma
A
- increased IOP
- retinal ischemia
- reduced or dysregulated blood flow
- extracellular matrix changes
3
Q
What can increase inflow of aqueous humor?
A
beta receptor stimulation
4
Q
What can decrease aqueous humor inflow?
A
- alpha 1 and 2 adrenergic stimulation
- beta receptor blocking
- DA blocking
- adenylate cyclase stimulation
5
Q
Classification Categories of Glaucoma
A
- primary: open angle, angle closure
- secondary: open angle, angle closure
- congenital
6
Q
Risk Factors for Primary Open Angle Glaucoma
A
- elevated IOP
- African or Hispanic descent
- family hx of glaucoma
- older age
- thinner central corneal thickness
7
Q
Possible Risk Factors for Primary Open Angle Glaucoma
A
- systemic HTN
- DM
- myopia
- low diastolic perfusion pressures
8
Q
List some drugs that may induce or potentiate glaucoma.
A
- corticosteroids: ophthalmic (high risk), systemic, inhaled/nasal
- ophthalmic anticholinergics
- vasodilators
- cimetidine
9
Q
POAG Diagnosis (what 3 things)
A
- disc changes
- visual field loss
- increased IOP
10
Q
When is pharmacologic tx of glaucoma considered effective?
A
when it stops progression of visual field loss
11
Q
Glaucoma Treatment Goals
A
- target IOP based on patient baseline IOP and existing visual field loss
- initial target at least 25% below baseline
12
Q
What are the 5 classes of drugs used in tx of glaucoma?
A
- beta blockers
- prostaglandin analogs
- alpha2 adrenergic agonists
- carbonic anhydrase inhibitors
- cholinergic agonists
13
Q
Beta Blockers MOA
A
decrease production of aqueous humor
14
Q
Beta Blockers AEs
A
- local: stinging on application, dry eyes, corneal anesthesia, blepharitis, blurred vision
- systemic: decreased HR and BP, bronchospasm, masked sx of hypoglycemia, CNS sedation
15
Q
Beta Blockers CIs
A
- asthma
- 2/3rd degree heart block
- bradycardia